SCHW heads into its October 15 earnings date with a notable divergence: the stock is holding near $107.79 while insiders have been selling in size and short interest has quietly rebuilt from mid-month lows.
The insider activity is the most striking data point this week. Co-Chairman Walter Bettinger sold 74,388 shares on August 28 at around $110.91, realising over $8.25 million — and crucially, that sale was not under a pre-arranged 10b5-1 plan, making it a discretionary move rather than a scheduled one. Co-Chairman Charles Schwab sold 117,000 shares on August 24 at roughly $113.20, a transaction worth $13.2 million, also outside any plan. Carolyn Schwab-Pomerantz, a director, followed with a $1 million open-market sale on August 26. The 90-day net across all insiders runs to roughly negative 1.25 million shares, worth approximately $135 million in aggregate — a cluster of discretionary selling from the most senior names on the register that is hard to dismiss as routine.
Short positioning tells a complementary story, even if it remains modest in absolute terms. Short interest jumped 39% over the past week to about 1.2% of the free float — still a low level in isolation, but the pace of the move is notable. The ORTEX short score ticked up from 28.4 to 30.2 over the same period, a steady drift rather than a spike. Borrow conditions remain entirely unrestrictive: availability is effectively unconstrained at well above 1,000%, and the cost to borrow is a negligible 0.34%. The lending market is not flashing any squeeze dynamics. Options, similarly, are calm — the put/call ratio at 0.86 is barely above its 20-day average of 0.86, with a z-score near zero. Positioning here looks more like a modest rebuild than a bearish conviction trade.
The Street is broadly constructive, though not without dissent. Morgan Stanley maintained its Overweight rating and raised its target to $136 in late July — the bull camp points to Schwab's dominant RIA custody franchise, growing wealth management penetration, and the self-help recovery story around NIM expansion as the securities portfolio reprices into higher-yielding assets. UBS and Barclays both raised targets around the same time, keeping Buy and Overweight ratings respectively. The counter-argument centres on expensive wholesale funding replacing outflowed deposits, rising deposit beta squeezing net interest margins, and regulatory capital requirements that could limit payment-for-order-flow economics. BMO Capital moved to the sidelines ahead of the July print, downgrading to Market Perform. The consensus mean target of $124.95 implies roughly 16% upside from current levels. At 14.5x trailing earnings and 3.6x book, valuation is undemanding relative to history; the PE has compressed about half a turn over the past month as the stock has slipped roughly 3%.
Institutional ownership adds a layer of context worth noting. Toronto-Dominion Bank remains on the activist register with a Schedule 13D/A filed in February 2025 — though at a reported 0.1% stake, this appears to reflect residual positioning from the terminated Schwab acquisition rather than an active campaign. As always with 13D/G disclosures, stakes are as-last-reported and holders dropping below the 5% threshold may not file again. Among the large passive holders, FMR (Fidelity) added nearly 4.7 million shares in the most recent reported period, the largest incremental move among the top-15 holders, suggesting at least one major fund manager was adding while the founders were selling.
The last quarterly print on July 21 saw the stock slip 1.7% on the day before recovering to a 3.3% gain over the following five sessions — a pattern that suggests the market tends to sell the immediate reaction before reassessing. With earnings five weeks out and the stock trading a few percent below where the insider selling occurred, the question into October 15 is less about franchise quality and more about whether NIM guidance can give the bulls enough to work with against a backdrop where the company's own senior insiders were clearly willing to reduce exposure at prices above today's.
See the live data behind this article on ORTEX.
Open SCHW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
